Journal of Capital Medical University ›› 2004, Vol. 25 ›› Issue (3): 349-352.

• 论著·临床研究 • Previous Articles     Next Articles

Relationship between Endothelial Nitric Oxide Synthase 4b/a Gene Polymorphism and Curative Effects of Valsartan in Hypertensive Patients

Hua Qi1, Li Dongbao1, Zou Haiqiang2, Chen Biao2, Pi Lin1, Liu Rongkun1   

  1. 1. Department of Cardiology, Xuanwu Hospital, Capital University of Medical Sciences;2. The Beijing Institute of Geriatrics
  • Received:2003-09-11 Revised:1900-01-01 Online:2004-07-15 Published:2004-07-15

Abstract: To investigate the response of patients with different endothelial nitric oxide synthase(eNOS) genotype (4b/a)to the treatment of angiotensin Ⅱ type 1 receptor antagonist (valsartan), 72 patients with hypertension were divided into two groups according to eNOS gene 4b/a polymorphism: aa+ab group (n=16)and bb group (n=56).All patients were treated with valsartan for 4 weeks and their blood pressure were measured.Effective rate of valsartan antihypertension in aa+ab group was 93.8%, but the effective rate in bb group was 64.3%.Curative effects of valsartan was significantly higher in aa+ab group than in bb group.It is suggested that eNOS 4b/a gene polymorphism can be used as one of adjustive indicators for predicting the effects of using angiotensin Ⅱ type 1 receptor antagonist in treatment of hypertensive patients.

Key words: gene polymorphism, angiotensin Ⅱ type 1 receptor antagonist, hypertension, response to treatment

CLC Number: